Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
11 Avril 2024 - 2:30PM
Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the
“Company”) today announced that Chief Executive Officer Steven
Quay, M.D., Ph.D., will speak at the Noble Capital Markets Emerging
Growth Healthcare Conference on Wednesday, April 17 at 9:00 am ET.
The presentation will be available virtually and members of the
Company’s leadership team will be available for one-on-one meetings
with registered investors of the conference. Atossa is a clinical
stage biopharmaceutical company developing innovative medicines in
areas of significant unmet medical need in oncology with a focus on
breast cancer.
Individuals interested in viewing the live presentation can
register for the free event here: Noble Healthcare Conference
Registration. A video replay of the presentation will be available
for 90 days following the event on the investor relations page of
Atossa’s website: https://investors.atossatherapeutics.com and on
Channelchek: www.channelchek.com.
About Atossa TherapeuticsAtossa Therapeutics,
Inc. is a clinical-stage biopharmaceutical company developing
innovative medicines in areas of significant unmet medical need in
oncology with a focus on using (Z)-endoxifen to prevent and treat
breast cancer. For more information, please visit
www.atossatherapeutics.com.
ContactEric Van ZantenVP, Investor and Public
Relations610-529-6219eric.vanzanten@atossainc.com
Atossa Therapeutics (NASDAQ:ATOS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Atossa Therapeutics (NASDAQ:ATOS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
